Early Markers of Disease and Response to Therapy

NCT04118153 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Abatacept

Sponsor

Sandra Lord, MD

Collaborators

[object Object]
[object Object]